Home
Gilead Sciences, 10% Owner: Arcus Biosciences RCUS Buy · Filed 24/01/31
Trade details
- Type
- Insider buy
- Amount
- $319,999,995
- Shares · price
- 15,238,095 sh · $21.00 a share
- Held after
- 30,061,124 sh
- Person
- Gilead Sciences10% Owner
- Trade date
- 24/01/29
- Filed
- 24/01/31
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 1 insiders
- Holding change
- +102.8%
Arcus Biosciences trades, last 26 weeks
What else happened in Arcus Biosciences around then
Filed or reported within 30 days of the trade day · 23/12/30~24/02/28Gilead Sciences's recent trades
- Gilead Sciences
BuyAssembly Biosciences
BuyAssembly Biosciences
ASMB
2,295,920 sh
price in footnote
2,295,920 sh
Filed 25/10/03
Traded 25/08/08
- Gilead Sciences
BuyArcus Biosciences
BuyArcus Biosciences
RCUS
$15M
1,363,636 sh
$15M
Filed 25/02/20
Traded 25/02/18
- Gilead Sciences
BuyAssembly Biosciences
BuyAssembly Biosciences
ASMB
$20.1M
940,499 sh
$20.1M
Filed 24/12/23
Traded 24/12/19
- Gilead Sciences
BuyXilio Therapeutics
BuyXilio Therapeutics
XLO
$1.8M
1,759,978 sh
$1.8M
Filed 24/12/19
Traded 24/12/18
- Gilead Sciences
BuyAssembly Biosciences
BuyAssembly Biosciences
ASMB
179,500 sh
price in footnote
179,500 sh
Filed 24/06/20
Traded 24/06/17
